Literature DB >> 25183160

The role of glial cells and the complement system in retinal diseases and Alzheimer's disease: common neural degeneration mechanisms.

Hannah Harvey1, Szonya Durant.   

Abstract

Many age-related degenerative diseases of the central nervous system (CNS) increasingly appear to have similarities in their underlying causes. By applying knowledge between disorders, and in particular between degenerative diseases of different components of the CNS (e.g. the eye and the brain), we can begin to elucidate general mechanisms of neural degeneration. Age-related macular degeneration and glaucoma, two diseases of retinal neurons, which have recently been discussed in view of their common mechanisms with Alzheimer's disease, highlight this perspective. This review discusses the common roles of the complement system (an immunological system) and glial cells (providing, amongst other functions, trophic support to neurons) in these three disorders. A number of facets of these systems would seem to be involved in the mechanisms of degeneration in at least two of the three diseases considered here. Regulatory proteins of the complement system (such as factor H), neurotrophin levels, and the interaction of microglia with the complement system in particular may be general to all three presentations of neural degeneration. Investigating the functioning of these fundamental systems across different diseases exemplifies the importance of considering advances in knowledge across a wider base than specific disease pathology. This may give insights both for understanding the function of these supporting systems and providing an avenue for developing future therapeutic targets general to neural degenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25183160     DOI: 10.1007/s00221-014-4078-7

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  134 in total

Review 1.  Microglia and neuroprotection: implications for Alzheimer's disease.

Authors:  Wolfgang J Streit
Journal:  Brain Res Brain Res Rev       Date:  2005-01-15

2.  Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease.

Authors:  Stefan Barghorn; Volker Nimmrich; Andreas Striebinger; Carsten Krantz; Patrick Keller; Bodo Janson; Michael Bahr; Martin Schmidt; Robert S Bitner; John Harlan; Eve Barlow; Ulrich Ebert; Heinz Hillen
Journal:  J Neurochem       Date:  2005-08-31       Impact factor: 5.372

3.  Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes.

Authors:  Kalliopi Stasi; Dalia Nagel; Xiaoyan Yang; Rong-Fang Wang; Lizhen Ren; Steven M Podos; Thom Mittag; John Danias
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-03       Impact factor: 4.799

Review 4.  Age related macular degeneration and drusen: neuroinflammation in the retina.

Authors:  Elisa Buschini; Antonio Piras; Raffaele Nuzzi; Alessandro Vercelli
Journal:  Prog Neurobiol       Date:  2011-06-28       Impact factor: 11.685

5.  Quantitative relations in the retinal ganglion cell layer of the rat: neurons, glia and capillaries before and after optic nerve section.

Authors:  M M Gellrich; N C Gellrich
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-05       Impact factor: 3.117

6.  Age-related changes of glycosidases in human retinal pigment epithelium.

Authors:  K A Cingle; R S Kalski; W E Bruner; C M O'Brien; P Erhard; R E Wyszynski
Journal:  Curr Eye Res       Date:  1996-04       Impact factor: 2.424

Review 7.  Common mechanisms of amyloid oligomer pathogenesis in degenerative disease.

Authors:  Charles G Glabe
Journal:  Neurobiol Aging       Date:  2006-02-14       Impact factor: 4.673

8.  The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration.

Authors:  Lincoln V Johnson; William P Leitner; Alexander J Rivest; Michelle K Staples; Monte J Radeke; Don H Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-20       Impact factor: 11.205

9.  Viewing ageing eyes: diverse sites of amyloid Beta accumulation in the ageing mouse retina and the up-regulation of macrophages.

Authors:  Jaimie Hoh Kam; Eva Lenassi; Glen Jeffery
Journal:  PLoS One       Date:  2010-10-01       Impact factor: 3.240

10.  Microglial aging in the healthy CNS: phenotypes, drivers, and rejuvenation.

Authors:  Wai T Wong
Journal:  Front Cell Neurosci       Date:  2013-03-13       Impact factor: 5.505

View more
  8 in total

Review 1.  Using genetic mouse models to gain insight into glaucoma: Past results and future possibilities.

Authors:  Kimberly A Fernandes; Jeffrey M Harder; Pete A Williams; Rebecca L Rausch; Amy E Kiernan; K Saidas Nair; Michael G Anderson; Simon W M John; Gareth R Howell; Richard T Libby
Journal:  Exp Eye Res       Date:  2015-06-24       Impact factor: 3.467

Review 2.  The value of nutritional supplements in treating Age-Related Macular Degeneration: a review of the literature.

Authors:  Sabrina Mukhtar; Balamurali K Ambati
Journal:  Int Ophthalmol       Date:  2019-07-16       Impact factor: 2.031

3.  Progressive inflammatory pathology in the retina of aluminum-fed 5xFAD transgenic mice.

Authors:  A I Pogue; P Dua; J M Hill; W J Lukiw
Journal:  J Inorg Biochem       Date:  2015-07-20       Impact factor: 4.155

4.  Low serum ficolin-3 levels are associated with severity and poor outcome in traumatic brain injury.

Authors:  Jian-Wei Pan; Xiong-Wei Gao; Hao Jiang; Ya-Feng Li; Feng Xiao; Ren-Ya Zhan
Journal:  J Neuroinflammation       Date:  2015-12-01       Impact factor: 8.322

5.  C5a Increases the Injury to Primary Neurons Elicited by Fibrillar Amyloid Beta.

Authors:  Michael X Hernandez; Pouya Namiranian; Eric Nguyen; Maria I Fonseca; Andrea J Tenner
Journal:  ASN Neuro       Date:  2017-02       Impact factor: 4.146

6.  Subretinal macrophages produce classical complement activator C1q leading to the progression of focal retinal degeneration.

Authors:  Haihan Jiao; Matt Rutar; Nilisha Fernando; Ted Yednock; Sethu Sankaranarayanan; Riemke Aggio-Bruce; Jan Provis; Riccardo Natoli
Journal:  Mol Neurodegener       Date:  2018-08-20       Impact factor: 14.195

7.  Complement Factor H Loss in RPE Cells Causes Retinal Degeneration in a Human RPE-Porcine Retinal Explant Co-Culture Model.

Authors:  Angela Armento; Aparna Murali; Julia Marzi; Ana C Almansa-Garcia; Blanca Arango-Gonzalez; Ellen Kilger; Simon J Clark; Katja Schenke-Layland; Charmaine A Ramlogan-Steel; Jason C Steel; Marius Ueffing
Journal:  Biomolecules       Date:  2021-11-03

8.  C1q propagates microglial activation and neurodegeneration in the visual axis following retinal ischemia/reperfusion injury.

Authors:  Sean M Silverman; Byung-Jin Kim; Garreth R Howell; Joselyn Miller; Simon W M John; Robert J Wordinger; Abbot F Clark
Journal:  Mol Neurodegener       Date:  2016-03-24       Impact factor: 14.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.